Targeted DNA Methylation Editing Using an All-in-One System Establishes Paradoxical Activation of EBF3

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Cutaneous melanoma incidence is rising globally, with metastasis driving mortality.
• Epigenetic factors, particularly DNA methylation, are implicated in melanoma metastasis.
• Conventional understanding holds that DNA promoter hypermethylation silences gene expression.

Purpose of the Study:

• To investigate the role of DNA methylation in melanoma metastasis.
• To explore the novel mechanism of paradoxical gene activation via DNA methylation.
• To validate this mechanism using a specific gene promoter (EBF3) in melanoma cells.

Main Methods:

• Utilized a CRISPR-SunTag All-in-one system for targeted DNA methylation editing of the EBF3 promoter.
• Employed bisulfite sequencing, quantitative PCR (qPCR), and RNA-Sequencing (RNA-Seq) for analysis.
• Validated methylation changes and their impact on gene expression.

Main Results:

• Successfully demonstrated targeted, highly effective methylation and demethylation of the EBF3 promoter.
• Observed corresponding changes in EBF3 gene expression, validating paradoxical DNA methylation.
• Provided novel insights into EBF3 gene function, potentially linked to IFN pathway signaling.

Conclusions:

• Challenges the paradigm that DNA methylation solely silences genes.
• Establishes a novel mechanism of gene activation through promoter hypermethylation.
• Suggests EBF3 may play a role in melanoma malignancy and metastasis via epigenetic regulation.